Study of 5HT3 and 5HT4 Receptors Expression in HT29 Cell Line and Human Colon Adenocarcinoma Tissues
- 1 March 2010
- journal article
- research article
- Vol. 13 (2) , 120-125
Abstract
Background: Serotonin (5HT) has been shown to be a mitogenic factor in several carcinomas. Its mitogenic effect is elicited through a wide range of 5HT receptor subtypes. In this study, the effects of 5HT, 5HT(3) (1-phenylbiguanide hydrochloride) and 5HT(4) (cisapride) agonists in promoting the growth of the HT29 cell line and the growth-inhibition effect of the 5HT(3) receptor antagonist (Y-25130 hydrochloride) and 5HT(4) receptor antagonist (RS 23597-190) were investigated. The expressions of 5HT(3) and 5HT(4) receptors in human colon cancer tissues and the HT29 cell line were studied. Methods: The growth-promoting and growth-inhibition effects of 5-HT, 5HT(3) and 5HT(4) agonists and antagonists on the HT29 cell line were studied using MTT assay. Receptor expression has been demonstrated by western blotting. Results: The results showed that 5HT, 5HT(3), and 5HT(4) agonists caused significant proliferation of HT29 cells. 5HT(3) and 5HT(4) receptor antagonists had an inhibitory effect on the growth of these cells. Western blot analysis gave bands from colon tissue extracts and the HT29 cell line. Conclusion: The results indicate which 5HT(3) and 5HT(4) receptors are significantly expressed in both colon cancer tissue and the HT29 cell line. Expression for the 5HT(3) receptor is more potent. Furthermore, 5HT plays a mitogenic role in colon cancer cells and antagonists of 5HT(3), and 5HT(4) receptors can inhibit cancer cell growth.Keywords
This publication has 9 references indexed in Scilit:
- The Role of Serotonin (5-Hydroxytryptamine 1A and 1B ) Receptors in Prostate Cancer Cell ProliferationJournal of Urology, 2006
- The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotoninBiochemical and Biophysical Research Communications, 2006
- The effect of serotonin and serotonin antagonists on bladder cancer cell proliferationBJU International, 2006
- Expression of the 5-HT2A Serotoninergic Receptor in Human Placenta and Choriocarcinoma Cells: Mitogenic Implications of SerotoninPlacenta, 2005
- Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell LinesEuropean Urology, 2005
- Fluoxetine increases extracellular levels of 3‐methoxy‐4‐hydroxyphenylglycol in cultured COLO320 DM cellsCell Biochemistry and Function, 2004
- Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosisCancer Chemotherapy and Pharmacology, 2004
- Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell linesThe Prostate, 2004
- A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.Molecular Pharmacology, 1988